Proprio Appoints Alf Grunwald to Board of Directors

Grunwald brings vast medical technology business building expertise to Proprio's board

Proprio, a leading medical technology company, announced that global investment leader, Alf Grunwald, has joined its Board of Directors. With decades of experience, Grunwald brings extensive leadership skills and strategic expertise to the Proprio team. a leading medical technology company, announced that global investment leader, Alf Grunwald, has joined its Board of Directors. With decades of experience, Grunwald brings extensive leadership skills and strategic expertise to the Proprio team. 

Grunwald is the CEO of Artprivat, an independent investment advisory firm. He currently holds board positions at Paragon 28, Realists, and Starlight Cardiovascular Inc. In the past, Grunwald was CEO of Deloitte ICS Group and a partner at global investment firm Warburg Pincus.

“As a board member at Proprio, I look forward to continuing the company’s impressive momentum in providing surgeons with a new and improved way of seeing,” said Grunwald. “I am excited to join a team that is pushing the boundaries of technology’s role in the operating room. I believe in Proprio’s platform and the benefits it provides to both surgeons and patients.”

"We are thrilled to have Alf Grunwald bring his stellar track record in medical technology development and investment to Proprio’s Board of Directors," said Gabriel Jones, CEO and co-founder of Proprio. "His insights into business development and strategy will contribute significantly to our mission of using technology to dramatically improve patient care. "

Prior to his current roles, Grunwald was an Associate Professor for Corporate Finance and Entrepreneurship at the University of Applied Science Offenburg from 2006 to 2016. His educational background includes a degree in engineering from the University of Applied Science Offenburg.